Home

Pfizer (PFE)

24.03
+0.06 (0.25%)
NYSE · Last Trade: Jun 24th, 12:14 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
10 Stocks That Pay $100 or More in Dividendsfool.com
Via The Motley Fool · June 23, 2025
2 S&P 500 Stocks on Our Watchlist and 1 to Think Twice About
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Via StockStory · June 23, 2025
The 5 Most Interesting Analyst Questions From Pfizer’s Q1 Earnings Call
Pfizer’s first quarter results drew a positive market response as management emphasized margin improvement and disciplined expense control, even as revenue declined. CEO Albert Bourla credited robust execution in key therapeutic areas, particularly oncology and internal medicine, for helping offset lower sales from COVID-related products. CFO Dave Denton highlighted the impact of productivity programs and a refined commercial approach, noting that adjusted operating expenses fell meaningfully due to ongoing cost realignment. Management acknowledged external pressures, including U.S. policy changes and lower COVID demand, but pointed to operational efficiency as a key factor supporting profitability.
Via StockStory · June 23, 2025
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'benzinga.com
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
Via Benzinga · June 20, 2025
1 Large-Cap Stock to Research Further and 2 to Turn Down
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
Via StockStory · June 20, 2025
Curious about the most active S&P500 stocks in today's session?chartmill.com
Looking for the most active stocks in the S&P500 index on Wednesday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
Via Chartmill · June 18, 2025
2 Top Stocks to Buy With Less Than $30fool.com
Via The Motley Fool · June 18, 2025
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yieldsbenzinga.com
Via Benzinga · June 18, 2025
Looking for the most active stocks in the S&P500 index on Tuesday?chartmill.com
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest trading volume and driving market activity.
Via Chartmill · June 17, 2025
Elizabeth Warren, Jan Schakowsky Reportedly Seek Answers From Pfizer, Amgen, And Others On Low Federal Tax Billsstocktwits.com
The Democratic lawmakers alleged that pharmaceutical companies avoided paying U.S. tax bills by shifting their profits to offshore subsidiaries in jurisdictions with significantly lower tax rates, such as Ireland and Bermuda, according to CNBC.
Via Stocktwits · June 17, 2025
Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stockfool.com
Via The Motley Fool · June 17, 2025
3 Unprofitable Stocks with Mounting Challenges
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Via StockStory · June 17, 2025
1 S&P 500 Stock to Keep an Eye On and 2 to Steer Clear Of
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Via StockStory · June 16, 2025
Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleasedstocktwits.com
Jefferies thinks big pharma companies are "still on the hunt" for deals.
Via Stocktwits · June 13, 2025
What's going on in today's session: S&P500 most active stockschartmill.com
Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
Via Chartmill · June 13, 2025
FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Upbenzinga.com
The U.S. Food and Drug Administration expanded approval of Moderna Inc.'s (NASDAQ: MRNA) respiratory syncytial virus vaccine.
Via Benzinga · June 13, 2025
3 Healthcare Stocks with Questionable Fundamentals
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 8.4%. This drawdown was discouraging since the S&P 500 held its ground.
Via StockStory · June 13, 2025
Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session.chartmill.com
Stay informed about the most active stocks in the S&P500 index on Thursday's session. Discover the stocks that are generating the highest trading volume and driving market activity.
Via Chartmill · June 12, 2025
BioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer Treatmentstocktwits.com
Under the terms of the deal, each CureVac share will be exchanged for approximately $5.46 in BioNTech American depositary shares.
Via Stocktwits · June 12, 2025
Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%fool.com
Via The Motley Fool · June 12, 2025
RFK Jr. Appoints Vaccine Critics To CDC Vaccine Panel After Firing Entire Advisory Committee: Reportbenzinga.com
Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC's Advisory Committee on Immunization Practices.
Via Benzinga · June 12, 2025
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Offfool.com
Steady growth and dividend increases over decades can make investors remarkably wealthy.
Via The Motley Fool · June 11, 2025
Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidiainvestors.com
Shares look likely to break out at the open after the biotech company unveiled promising results for a pulmonary arterial hypertension treatment.
Via Investor's Business Daily · June 10, 2025
2 Weight Loss Drug Stocks That Are Screaming Buys in Junefool.com
These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing next-generation offerings.
Via The Motley Fool · June 10, 2025
Robert Kennedy Jr Axes Entire CDC Vaccine Panel To 'Restore Public Trust' — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Tradingbenzinga.com
A sweeping overhaul of the CDC's top vaccine advisory panel is ripping through the medical world, while rattling pharma and biotech stocks.
Via Benzinga · June 10, 2025